EVAX Evaxion Biotech: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization

Brandmark of Evaxion (EVAX)

Evaxion Biotech A/S (EVAX) relies on proprietary AI algorithms while outsourcing drug synthesis and testing to external contractors. The effectiveness of immunotherapy renders the business independent of market cycles, although the macro environment influences the stock's valuation. This chart illustrates an EV/EBITDA of 0.00. The growth strategy is based on patenting proprietary models and seeking partnerships with pharmaceutical behemoths without pursuing merger and acquisition deals.

EVAX (Evaxion Biotech) Business Value to Operating Income Before Depreciation history from 11/23/2025 to 11/10/2026

Analytical breakdowns for Evaxion Biotech A/S

- market price and analyst price targets:
Price Chart Evaxion Biotech Corp|EVAX - Average Forecast Price
- company stock capitalization data:
Market Value Evaxion Biotech AS|EVAX - Business Value
- book value of equity indicators:
Accounting Value per Share Evaxion|EVAX - Accounting Value of Company|Market Capitalization to Book Value Ratio evaxion-biotech.com|EVAX - Aggregate Company Assets
- company total debt and liquidity indicators:
Total Debt to Capital Evaxion Biotech A/S|EVAX - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Evaxion|EVAX - Company Cumulative Debt|Debt to Book Value Evaxion Biotech AS|EVAX - Amount of Long-Term Liabilities|Company Short-Term Debts Evaxion|Quick Ratio evaxion-biotech.com
- net income and valuation multiples indicators:
EVAX - Net Income|Projected Future Earnings Evaxion Biotech A/S|EVAX - Company Value to Net Income|Projected Price to Earnings Evaxion Biotech A/S|EVAX - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Evaxion Biotech AS|EVAX - Operating profit EBITDA|Earnings per share for the last twelve months Evaxion|EVAX - Net earnings per share for the last four quarters|Quarterly EPS earnings growth evaxion-biotech.com|EVAX - Earnings per share growth rate in current year|Expected earnings per share growth for next year Evaxion Biotech A/S
Initial company analysis:Evaxion Biotech Corp (EVAX)
Product sample of Evaxion

This ratio compares the total enterprise value of a business with its operating profit before depreciation and interest, allowing for an assessment of the real value of assets adjusted for debt load. For Evaxion Biotech (EVAX), which is developing AI platforms for cancer vaccines in partnership with pharma behemoths, the EV/EBITDA trend of this capital-intensive business serves as an indicator of the efficiency of capitalizing scientific research and the sustainability of financial leverage.

Competing companies

Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Nvidia Corp NVDA|CoreWeave Corp (CRWV) - Company Value to EBITDA|NBIS - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|SOUN (soundhound.com) - Enterprise Value to Operating Income Before Depreciation|ZETA (Zeta Global Corp) - Enterprise Value to EBITDA Ratio|Pagaya Technologies Ltd. - Business Value to Operating Income Before Depreciation|AI (C3 AI) - EV/EBITDA Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization RXRX|EV/EBITDA Multiple RZLV|Total Company Value to Operating Income Before Depreciation Ratio superx.sg|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Ginkgo Bioworks Inc DNA|Cerence Inc (CRNC) - Company Value to EBITDA|PDYN: Enterprise Value to EBITDA Ratio|Veritone, Inc. - Enterprise Value to Operating Income Before Depreciation Ratio|MIMI: EV/EBITDA Multiple|Company Value to EBITDA MicroAlgo (MLGO)|HPAI (Helport AI Ltd.) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio LivePerson Inc (LPSN)|EV/EBITDA Multiple QUIK|SST (system1.com) - Business Value to Operating Income Before Depreciation|Datavault AI Inc - Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation RYET|Webus International - EV/EBITDA Multiple|MCRP - EV/EBITDA Multiple|cyngn.com (CYN) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|YYAI - Total Company Value to Operating Income Before Depreciation Ratio|HOLO (MicroCloud Hologram, Inc.) - EV/EBITDA Multiple|Company Value to EBITDA infraredcameras.com MSAI|Enterprise Value to EBITDA Ratio AIXI (Xiao-I Corporation)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization CXAI (CXApp Inc)|EV/EBITDA Multiple BNAI (Brand Engagement Network Inc.)|EV/EBITDA Multiple Gaxos.ai Inc GXAI|EVGN: Enterprise Value to EBITDA Ratio|IFBD (Infobird Co., Ltd) - Enterprise Value to Operating Income Before Depreciation|TAOP: EV/EBITDA Multiple|VERSES AI (VSAI) - EV/EBITDA Multiple|EXAI (Exscientia PLC) - EV/EBITDA Multiple|FOXO Technologies, Inc. (FOXO) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple VHAI|ZPTA - Company Value to EBITDA